Sindrome dell'intestino corto: dimensioni, segmenti e analisi del mercato entro il 2025-2031
Short Bowel Syndrome Market Report Analysis
Short Bowel Syndrome Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Takeda Pharmaceutical Company Limited
- Zealand Pharma A/S
- VectivBio AG
- 9 Meters Biopharma, Inc
- Hanmi Pharm.Co.,Ltd
- GlaxoSmithKline, Plc
- Cadila Pharmaceuticals
- Sun Pharmaceutical Industries Ltd
- Troikaa
Regional Overview
- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation
By Classe di farmaci
- peptidi simili al glucagone
- bloccanti H2
- inibitori della pompa protonica
- altri
By Canale distributivo
- Farmacie ospedaliere
- Farmacie al dettaglio
- Vendite online
By Geografia
- America del Nord
- Europa
- Asia-Pacifico
- America centrale e meridionale
Get Free Sample For